Journal of Drugs in Dermatology Publishes Phase 2 Data for New Acne Treatment

Posted by Laura Swartz

June 15, 2015 at 11:36 AM

  • Data show that MABp1 has led to rapid improvement in skin lesions and acne-associated psychological symptoms.

  • Findings are published in the June 2015 issue of Journal of Drugs in Dermatology. (J Drugs Dermatol. June 2015;14(6):560-564)

Read More

Topics: Xbiotech, xbit

60-page Report on Newly Public Company XBiotech Inc. (XBIT-NASDAQ)

Posted by Laura Swartz

May 27, 2015 at 2:10 PM

Crystal Research Associates has released a new Executive Informational Overview (EIO) on XBiotech Inc. (XBIT-NASDAQ), a company engaged in discovering, developing, and translating natural human immunity into novel therapeutic antibody products. The 60-page EIO, which details XBiotech's business, technology and product development, manufacturing expertise, market opportunities, competition, and more, is available for download below.

Read More

Topics: xbit

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic